I have not written about Cervus Equipment (TSX: CERV) before, but I took a small position in them last autumn. Unfortunately the size I received was less than what I wanted, because the stock took off shortly after. You can see the candlestick where my limit orders were filled (I won’t highlight it, but it definitely sticks out):
This is part of my ‘real world’ economy theme, where Cervus is a farm equipment retailer and practically anything relating to agriculture post-Covid is going to be heading up. They used to be twins with their competitor, Rocky Mountain Equipment (now delisted because they went private in a management-assisted buyout), but aside from John Deere (NYSE: DE), there aren’t really any good comparables in the farm space.
Given the business of selling equipment and servicing, perhaps the best analogy is with an auto dealership, and Autozone / AutoCanada (NYSE: AZO / TSX: ACQ) fit this particular bill.
Indeed, given the record level (both quantity and price) of used automobile sales occurring, perhaps it is not that surprising that the same is being encountered in the agricultural equipment space. The company has markedly improved its inventory balances ($320 million at end-of-2019 to $229 million at end-of-2020). The question is whether this had anything to do with management’s explicit actions or whether they are just the recipient of people spending money on farm equipment since they can’t do anything else during the Covid lockdown.
In a retailing environment, there is high sensitivity to gross margins and also the cost of getting those margins (SG&A). In 2020 vs. 2019, the contrast was pretty clear, revenues were up, margins were up, and SG&A was down, so this made for a very successful year (about $25 million in income, plus some favourable FX to boot). Balance sheet-wise, tangible book value is $12.26/share, and they eliminated the majority of their bank debt (clearing out net $91 million in inventory would help, noting that a good chunk of that is supported by short-term vendor floor plan financing, note 11 on the financials for those interested in following along).
During the year, CERV was able to repurchase approx. 290,000 shares at an average of $7.35 a piece, which offset some dilution on the share purchase plan. They also have financial room to raise the dividend, which they did – from $0.06/share quarterly to $0.11/share, which is what the dividend was before this Covid-19 mess began.
All things considered, a very good quarter for the company. While not at a valuation I would purchase the company, they are not in nosebleed territory by any stretch. If they receive a growth valuation, there’s further room to go on the stock price.
(Update, March 12, 2021: After hitting the “post” button, I noticed on my Twitter feed that Jason at Chapter 12 Capital did a small bit on it, a few hours before this article went out. Great minds think alike… let’s hope.)